ストックスクリーナーアプリを入手
1.25
5.30%
-0.07
プレマーケット:
1.26
0.01
+0.80%
前日終値:
$1.32
開ける：
$1.28
24時間の取引高:
272.04K
Relative Volume:
0.07
時価総額：
$21.77M
収益：
$174.80K
当期純損益:
$-8.85M
株価収益率:
-1.815
EPS:
-0.6887
ネットキャッシュフロー:
$-4.37M
1週間 パフォーマンス:
-18.30%
1か月 パフォーマンス:
+34.77%
6か月 パフォーマンス:
-0.79%
1年 パフォーマンス:
-58.19%
1日の値動き範囲:
$1.205
$1.3298
1週間の範囲:
$1.205
$1.60
52週間の値動き範囲:
$0.702
$4.4899
Nexalin Technology Inc Stock (NXL) Company Profile
NXL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NXL
Nexalin Technology Inc
|
1.25 | 24.01M | 174.80K | -8.85M | -4.37M | -0.6887 |
|
ABT
Abbott Laboratories
|
124.95 | 216.56B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
99.05 | 146.61B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.81 | 136.78B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.06 | 115.95B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.44 | 48.64B | 5.88B | 1.34B | 577.90M | 2.3455 |
Nexalin Technology Inc (NXL) 最新ニュース
Statistical indicators supporting Nexalin Technology Inc.’s strength2025 Dividend Review & Weekly Top Gainers Alerts - newser.com
What high frequency data says about Nexalin Technology Inc. Equity WarrantVolume Spike & Proven Capital Preservation Methods - newser.com
Price momentum metrics for Nexalin Technology Inc. explainedTrade Volume Summary & High Accuracy Investment Signals - newser.com
Trend analysis for Nexalin Technology Inc. this weekTrade Ideas & Fast Moving Stock Watchlists - newser.com
Published on: 2025-11-07 02:03:22 - newser.com
What drives Nexalin Technology Inc Equity Warrant stock priceLong-Term Growth Stocks & Small Entry Cost Portfolio - earlytimes.in
Published on: 2025-11-06 09:49:32 - newser.com
Is Nexalin Technology Inc. forming a bottoming baseQuarterly Trade Review & Weekly Market Pulse Updates - newser.com
Is a relief rally coming for Nexalin Technology Inc. Equity Warrant holdersEntry Point & High Accuracy Swing Trade Signals - newser.com
How analysts rate Nexalin Technology Inc. stock todayQuarterly Earnings Summary & Fast Entry Momentum Trade Alerts - fcp.pa.gov.br
Evaluating Nexalin Technology Inc. with trendline analysisPortfolio Return Summary & AI Driven Stock Reports - newser.com
Is this a good reentry point in Nexalin Technology Inc.July 2025 Closing Moves & Free Low Drawdown Momentum Trade Ideas - newser.com
How Nexalin Technology Inc. stock compares to industry benchmarksGap Down & AI Powered Trade Plan Recommendations - newser.com
Momentum divergence signals in Nexalin Technology Inc. chart2025 Retail Activity & Low Risk Entry Point Tips - newser.com
Will Nexalin Technology Inc. Equity Warrant stock benefit from AI adoption2025 EndofYear Setup & Safe Swing Trade Setups - newser.com
How to monitor Nexalin Technology Inc. with trend dashboardsMarket Risk Report & AI Enhanced Execution Alerts - newser.com
Why Nexalin Technology Inc. stock is in analyst buy zone2025 Big Picture & Fast Gaining Stock Reports - newser.com
Will Nexalin Technology Inc. Equity Warrant stock benefit from automation2025 Year in Review & Smart Money Movement Tracker - newser.com
Will Nexalin Technology Inc. Equity Warrant stock deliver better than expected guidanceMarket Growth Summary & Reliable Entry Point Alerts - fcp.pa.gov.br
Is Nexalin Technology Inc. stock a buy for dividend growth2025 Investor Takeaways & Risk Controlled Stock Pick Alerts - newser.com
How to monitor Nexalin Technology Inc. Equity Warrant with trend dashboards2025 Market Outlook & Risk Managed Investment Strategies - newser.com
FDA accepts Nexalin’s submission for Alzheimer’s treatment device By Investing.com - Investing.com Nigeria
Can Nexalin Technology Inc. stock reach $100 price targetTrade Analysis Summary & Low Risk Entry Point Tips - newser.com
Should you wait for a breakout in Nexalin Technology Inc.July 2025 Review & High Conviction Investment Ideas - newser.com
How high can Nexalin Technology Inc. stock goWeekly Profit Summary & Weekly Top Performers Watchlists - newser.com
Detecting support and resistance levels for Nexalin Technology Inc.July 2025 Analyst Calls & Daily Profit Maximizing Trade Tips - newser.com
Can Nexalin Technology Inc. stock double in next 5 yearsWeekly Risk Report & Safe Capital Preservation Plans - newser.com
Is it too late to sell Nexalin Technology Inc.2025 Investor Takeaways & Weekly Top Gainers Alerts - newser.com
Can Nexalin Technology Inc. stock outperform in 2025 bull market2025 Key Lessons & Daily Volume Surge Trade Alerts - newser.com
How geopolitical tensions affect Nexalin Technology Inc. stockGold Moves & Technical Entry and Exit Tips - newser.com
Analyzing drawdowns of Nexalin Technology Inc. with statistical toolsWeekly Gains Report & Expert Approved Trade Ideas - newser.com
FDA accepts Nexalin’s submission for Alzheimer’s treatment device - Investing.com
How resilient is Nexalin Technology Inc. stock in market downturnsEarnings Risk Summary & Low Risk Entry Point Guides - fcp.pa.gov.br
What valuation multiples suggest for Nexalin Technology Inc. stockJuly 2025 Closing Moves & Free Fast Gain Swing Trade Alerts - fcp.pa.gov.br
Nexalin Technology Inc. (NXL) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Can Nexalin Technology Inc. stock continue upward trendJuly 2025 Review & Expert Verified Stock Movement Alerts - fcp.pa.gov.br
Nexalin Technology announces FDA acceptance of Q-Sub for Gen-2 SYNC - TipRanks
Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for the Treatment of Alzheimer’s Disease and Dementia - The Manila Times
Nexalin Tech (Nasdaq: NXL) FDA accepts Q-Submission for Gen-2 SYNC in Alzheimer’s, dementia - Stock Titan
Detecting price anomalies in Nexalin Technology Inc. Equity Warrant with AIJuly 2025 Pullbacks & Daily Market Momentum Tracking - newser.com
Published on: 2025-11-05 03:23:27 - newser.com
Will Nexalin Technology Inc. stock sustain high P E ratiosPortfolio Return Report & Weekly Market Pulse Updates - newser.com
Published on: 2025-11-05 02:08:21 - newser.com
Published on: 2025-11-05 00:25:20 - newser.com
Tick level data insight on Nexalin Technology Inc. volatilityWeekly Investment Report & Fast Momentum Entry Tips - newser.com
Can momentum traders help lift Nexalin Technology Inc.2025 AllTime Highs & Accurate Trade Setup Notifications - newser.com
Nexalin Technology Inc (NXL) 財務データ
収益
当期純利益
現金流量
EPS
Nexalin Technology Inc (NXL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Shelton Carolyn Hamby | Sr. VP - Quality, Regulatory |
Mar 12 '25 |
Buy |
2.20 |
6,000 |
13,200 |
30,000 |
| Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
3.10 |
1,000 |
3,100 |
155,793 |
| Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
2.98 |
1,000 |
2,980 |
154,793 |
| Owens David | Chief Medical Officer |
Jan 28 '25 |
Buy |
2.70 |
1,500 |
4,050 |
153,793 |
| Owens David | Chief Medical Officer |
Jan 13 '25 |
Buy |
2.50 |
2,000 |
5,000 |
151,293 |
| Owens David | Chief Medical Officer |
Jan 23 '25 |
Buy |
2.70 |
1,000 |
2,700 |
152,293 |
2.13%
2.85%
大文字化:
|
ボリューム (24 時間):